Učitavanje...

Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy

AIMS: Health Canada has developed a pathway to approve drugs that have limited efficacy and safety data, the Notice of Compliance with conditions (NOC/c) policy. Increased safety reporting is required for these drugs but there has not been any systematic review of their post-market safety. This stud...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Clin Pharmacol
Glavni autor: Lexchin, Joel
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4415721/
https://ncbi.nlm.nih.gov/pubmed/25393960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12552
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!